| Filed On | Filing |
|---|---|
| 11 Sep 2026 |
Form 4: Sibold William John, Director
Sold 6,362 shares ($3.41M) · Sold 5,221 shares ($2.83M) |
| 20 Aug 2026 |
Form 4: Kelley Shannon T, General Counsel
Sold 664 shares ($342K) |
| 18 Aug 2026 |
Form 4: Reed John C, Director
Received 647 shares as a grant or award · Granted 1,078 Stock Option (Right to Buy) |
| 20 Jul 2026 |
Form 4: Sibold William John, Director
Received 50,000 shares by exercise or conversion · Sold 2,500 shares ($1.37M) |
| 18 Jun 2026 |
Form 4: Taub Rebecca, Director
Received 454 shares as a grant or award · Granted 766 Stock Option (Right to Buy) |
| 18 Jun 2026 |
Form 4: Levy Richard S, Director
Received 454 shares as a grant or award · Granted 766 Stock Option (Right to Buy) |
| 18 Jun 2026 |
Form 4: Fouse Jacqualyn A, Director
Received 454 shares as a grant or award · Granted 766 Stock Option (Right to Buy) |
| 18 Jun 2026 |
Form 4: Daly James M, Director
Received 454 shares as a grant or award · Granted 766 Stock Option (Right to Buy) |
| 18 Jun 2026 |
Form 4: Brennan Daniel J., Director
Received 404 shares as a grant or award · Granted 681 Stock Option (Right to Buy) |
| 18 Jun 2026 |
Form 4: Baker Bros. Advisors Lp, Director and 5 others
Received 1,816 shares as a grant or award · Granted 3,064 Non-Qualified Stock Options (right to buy) |
| 01 Jun 2026 |
Form 4: Soergel David, Chief Medical Officer
Sold 1,042 shares ($517K) |
| 22 May 2026 |
Form 4: Levy Richard S, Director
Sold 5,682 shares ($2.93M) |
| 18 May 2026 |
Form 4: Soergel David, Chief Medical Officer
Sold 844 shares ($435K) |
| 06 Mar 2026 |
Form 4: Dier Mardi, EVP and CFO
Received 5,215 shares as a grant or award · Granted 6,519 Stock Option (Right to Buy) · Sold 1,982 shares ($854K) |
| 06 Mar 2026 |
Form 4: Sibold William John, Director
Received 14,995 shares as a grant or award · Granted 18,743 Stock Option (Right to Buy) · Sold 1,663 shares ($718K) |
| 06 Mar 2026 |
Form 4: Kelley Shannon T, General Counsel
Received 4,017 shares as a grant or award · Granted 5,022 Stock Option (Right to Buy) · Sold 360 shares ($155K) |
| 06 Mar 2026 |
Form 4: Huntsman Carole, Chief Commercial Officer
Received 3,989 shares as a grant or award · Granted 4,986 Stock Option (Right to Buy) · Sold 419 shares ($181K) |
| 06 Mar 2026 |
Form 4: Taub Rebecca, Director
Sold 491 shares ($212K) |
| 06 Mar 2026 |
Form 4: Soergel David, Chief Medical Officer
Received 4,374 shares as a grant or award · Granted 5,467 Stock Option (Right to Buy) |
| 02 Mar 2026 |
Form 4: Dier Mardi, EVP and CFO
Sold 1,183 shares ($505K) |
Loading...